Invezz

NexGel (NXGL)

Nasdaq Market Closed

NexGel, Inc. is a healthcare materials and consumer products company focused on hydrogels: water-rich polymer gels that can be engineered for direct contact with skin and tissue. Its core capability is the production of high-water-content, electron beam cross-linked aqueous polymer hydrogels. This manufacturing approach allows the company to create sterile, flexible, and absorbent gel materials used in applications such as wound care, diagnostic electrodes, transdermal delivery systems, and cosmetic treatments.

The company serves both business-to-business customers and consumer markets. For medical and healthcare clients, NexGel develops and manufactures customized gel components that may be incorporated into wound dressings, pads, electrodes, or other products where moisture management, cushioning, cooling, or skin compatibility are important. Its hydrogel technology can be adapted through variations in formulation, coating, mixing, and cross-linking processes, giving customers a way to tailor gels for specific performance requirements.

NexGel also markets consumer-facing products built around its gel expertise, including items positioned for skin care, beauty, pain relief, and over-the-counter wound care. This combination of contract manufacturing and branded products distinguishes the company from firms that operate only as materials suppliers.

As a listed micro-cap healthcare and materials stock, NexGel’s investment profile is tied to its ability to commercialize specialized gel products, win manufacturing relationships, expand retail or direct-to-consumer distribution, and scale production efficiently. The company operates in niche markets where product quality, regulatory awareness, and manufacturing consistency are central to customer adoption.

0.59 USD
0.59 USD
+0.01 (+0.86%)
After-hours

Last updated

Market Cap
5.39M
P/E
P/FCF
P/S
0.48
Enterprise Value
7.95M
Sector
Health Care
Industry
Surgical and Medical Instruments and Apparatus
Address
2150 CABOT BLVD WEST,, LANGHORNE, PA, 19047
GlobeNewswire Inc.

NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

Apr 17, 2026, 15:37 PM
GlobeNewswire Inc.

NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx

Dec 11, 2025, 08:00 AM
GlobeNewswire Inc.

NEXGEL to Report First Quarter 2025 Financial Results on May 13th

May 09, 2025, 09:00 AM
GlobeNewswire Inc.

NEXGEL Announces $2,000,000 Registered Direct Offering

Nov 11, 2024, 17:35 PM
GlobeNewswire Inc.

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

Oct 04, 2024, 09:00 AM
Investing.com

NEXGEL projects increased revenue in upcoming quarters - Investing.com

Jul 08, 2024, 16:17 PM
GlobeNewswire Inc.

NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America

Jun 11, 2024, 08:40 AM
GlobeNewswire Inc.

NEXGEL Acquires International Beauty Brand, Silly George

May 16, 2024, 09:00 AM
GlobeNewswire Inc.

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

Apr 01, 2024, 07:50 AM
GlobeNewswire Inc.

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

Mar 04, 2024, 08:30 AM
GlobeNewswire Inc.

NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024

Jan 09, 2024, 08:30 AM
GlobeNewswire Inc.

NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd

Sep 26, 2023, 09:49 AM
GlobeNewswire Inc.

NEXGEL to Report Second Quarter 2023 Financial Results on August 14th

Aug 02, 2023, 09:00 AM
GlobeNewswire Inc.

NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North America

Jul 19, 2023, 09:10 AM
GlobeNewswire Inc.

NEXGEL to Report First Quarter 2023 Financial Results on May 15th

May 09, 2023, 09:15 AM
GlobeNewswire Inc.

NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 27, 2023, 16:05 PM
GlobeNewswire Inc.

NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th

Mar 15, 2023, 07:30 AM
GlobeNewswire Inc.

NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business

Mar 02, 2023, 08:30 AM
GlobeNewswire Inc.

NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds

Dec 08, 2022, 07:30 AM
GlobeNewswire Inc.

NEXGEL Reports Third Quarter 2022 Financial Results

Nov 08, 2022, 16:11 PM
Market Cap
5.39M
Enterprise Value
7.95M
P/E
P/B
1.35
P/S
0.48
EV / EBITDA
-2.56
EV / Sales
0.71
EPS
-0.35
Dividend Yield
0%
P/FCF
P/CF
Free Cash Flow
-1.49M
ROE
-80.5%
ROA
-27.72%
Debt / Equity
0.69
Current Ratio
1.12
Quick Ratio
0.44
Cash
0.06
Avg Volume
156.03K
Fundamentals Snapshot Price
0.59

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 2.65M 2.8M 2.93M 2.88M 2.81M
Gross profit 1.06M 819K 1.24M 1.26M 1.19M
Operating income -958K -1.21M -725K -636K -777K
EBITDA -859K -1.1M -612K -537K -663K
Net income -927K -970K -653K -665K -712K
Basic EPS -0.11 -0.12 -0.08 -0.09 -0.09
Diluted EPS -0.11 -0.12 -0.08 -0.09 -0.09

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 11.6M 10.46M 11.62M 9.71M 10.44M
Total liabilities 7.12M 5.57M 6.04M 4.66M 4.87M
Total equity 4.48M 4.89M 5.58M 5.06M 5.57M
Cash & equivalents 208K 317K 938K 725K 1.19M
Current assets 3.72M 3.6M 4.68M 4.16M 4.74M
Current liabilities 3.31M 2.96M 3.31M 2.4M 2.52M

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow -504K 281K -785K -407K -400K
Investing cash flow -9K -40K -8K -20K
Financing cash flow 1.58M -1.04M 1.93M -40K -215K
Change in cash 1.06M -800K 1.13M -467K -615K
Kind Filing Date Link
edgar index PRE 14A — NEXGEL, INC. View Filing
edgar index 4 — NEXGEL, INC. View Filing
form 4 Form 4 — Levy Adam R. View Filing
form 4 Form 4 — Levy Adam R. View Filing
edgar index 144 — NEXGEL, INC. View Filing
form 4 Form 4 — Levy Adam R. View Filing
edgar index 3 — NEXGEL, INC. View Filing
edgar index 3 — NEXGEL, INC. View Filing
edgar index 4 — NEXGEL, INC. View Filing
edgar index 4 — NEXGEL, INC. View Filing
edgar index 4 — NEXGEL, INC. View Filing
form 3 Form 3 — Kieser Brian Joseph View Filing
form 3 Form 3 — Kieser Brian Joseph View Filing
edgar index 8-K — NEXGEL, INC. View Filing
eight k text 8-K — 8-K View Filing
edgar index 10-Q — NEXGEL, INC. View Filing
form 4 Form 4 — Levy Adam R. View Filing
form 4 Form 4 — Levy Adam R. View Filing
form 4 Form 4 — Henry Scott Robert View Filing
form 4 Form 4 — Henry Scott Robert View Filing
edgar index 8-K — NEXGEL, INC. View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — Kieser Brian Joseph View Filing
form 4 Form 4 — Kieser Brian Joseph View Filing
edgar index 3 — NEXGEL, INC. View Filing
form 3 Form 3 — Blackman Ian Howard View Filing
form 3 Form 3 — Blackman Ian Howard View Filing
form 3 Form 3 — Blackman Ian Howard View Filing
edgar index SCHEDULE 13G/A — NEXGEL, INC. View Filing
edgar index 8-K — NEXGEL, INC. View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — NEXGEL, INC. View Filing
eight k text 8-K — 8-K View Filing
edgar index SCHEDULE 13G — NEXGEL, INC. View Filing
edgar index 8-K — NEXGEL, INC. View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — NEXGEL, INC. View Filing
eight k text 8-K — 8-K View Filing
edgar index 424B5 — NEXGEL, INC. View Filing
edgar index 8-K — NEXGEL, INC. View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — NEXGEL, INC. View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — NEXGEL, INC. View Filing
form 4 Form 4 — Levy Adam R. View Filing
edgar index 144 — NEXGEL, INC. View Filing
form 4 Form 4 — Levy Adam R. View Filing
edgar index 8-K — NEXGEL, INC. View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — NEXGEL, INC. View Filing
eight k text 8-K — 8-K View Filing
edgar index 10-Q — NEXGEL, INC. View Filing
edgar index 8-K — NEXGEL, INC. View Filing
edgar index 4 — NEXGEL, INC. View Filing
form 4 Form 4 — Levy Adam R. View Filing
edgar index DEF 14A — NEXGEL, INC. View Filing
edgar index PRE 14A — NEXGEL, INC. View Filing
edgar index 4 — NEXGEL, INC. View Filing
edgar index 4 — NEXGEL, INC. View Filing
form 4 Form 4 — Levy Adam R. View Filing
form 4 Form 4 — Henry Scott Robert View Filing
edgar index 144 — NEXGEL, INC. View Filing
form 4 Form 4 — Levy Adam R. View Filing
form 4 Form 4 — Henry Scott Robert View Filing
edgar index 4 — NEXGEL, INC. View Filing
edgar index 144 — NEXGEL, INC. View Filing
form 4 Form 4 — Henry Scott Robert View Filing
edgar index 4 — NEXGEL, INC. View Filing
edgar index 144 — NEXGEL, INC. View Filing
form 4 Form 4 — Levy Adam R. View Filing
edgar index 8-K — NEXGEL, INC. View Filing
edgar index 10-Q — NEXGEL, INC. View Filing
edgar index 8-K — NEXGEL, INC. View Filing
edgar index 3 — NEXGEL, INC. View Filing
form 3 Form 3 — Ciardiello Steven View Filing